Global Spine Journal · Nov 16, 2026

Differential Performance of Cervical Vertebral Bone Quality Score and Hounsfield Units Across High-Density Lipoprotein Cholesterol Levels

By Wang Y, Feng T, Xiang Z et al.

Study Design: Retrospective observational study. Objective: The association between lipid metabolism and bone metabolism has garnered widespread attention recently. This study aimed to systematically investigate the differential modifying effects of high-density lipoprotein cholesterol (HDL-C) on the discriminatory performance of the cervical vertebral bone quality (C-VBQ) score and cervical Hounsfield units (C-HU) for assessing bone quality. Methods: Spearman correlation analysis was performed to evaluate the correlations of HDL-C with C-VBQ scores and C-HU. Binary logistic regression and receiver operating characteristic (ROC) analyses were performed to evaluate the associations of HDL-C with DEXA-defined impaired bone quality and the performance of C-VBQ score and C-HU across HDL-C strata. Continuous HDL-C interaction models, likelihood-ratio tests, bootstrap validation, and restricted cubic spline analyses were additionally performed to assess potential effect modification. Results: Multivariable logistic regression demonstrated that higher HDL-C levels were independently associated with impaired bone quality (P<0.001). HDL-C was positively correlated with the C-VBQ score (r=0.461, P<0.001). In the high HDL-C subgroup, the C-VBQ score demonstrated greater discriminatory performance than C-HU for identifying impaired bone quality, with an AUC of 0.816 versus 0.740 (P<0.001). Continuous interaction analysis revealed a significant interaction between C-VBQ score and HDL-C (OR=2.654, P=0.017), which was supported by likelihood-ratio testing, bootstrap validation, and restricted cubic spline analysis. Conclusions: Elevated HDL-C was associated with DEXA-defined impaired bone quality, and the association of C-VBQ score with this outcome varied according to HDL-C levels. In patients with elevated HDL-C, C-VBQ score demonstrated greater discriminatory performance than C-HU for identifying DEXA-defined impaired bone quality.

doi.org/10.1177/21925682261509536PubMed 43038483Biomarkers

AgingResearch.News